| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1146/ANNUREV.PS.43.020192.001511 |
| P698 | PubMed publication ID | 1539945 |
| P2093 | author name string | D. C. Fowles | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| schizophrenic psychology | Q69941090 | ||
| P304 | page(s) | 303-336 | |
| P577 | publication date | 1992-01-01 | |
| P1433 | published in | Annual Review of Psychology | Q15762820 |
| P1476 | title | Schizophrenia: diathesis-stress revisited | |
| P478 | volume | 43 |
| Q35592037 | Abnormal glucocorticoid receptor mRNA and protein isoform expression in the prefrontal cortex in psychiatric illness. |
| Q58184542 | Adoption Studies of Schizophrenia |
| Q48884423 | An association between reduced interhemispheric EEG coherence in the temporal lobe and genetic risk for schizophrenia |
| Q99548932 | Assessing the Relationship between Sense of Agency, the Bodily-Self and Stress: Four Virtual-Reality Experiments in Healthy Individuals |
| Q34492915 | Cardiac Coherence Training to Reduce Anxiety in Remitted Schizophrenia, a Pilot Study |
| Q37682586 | Cav1.2 channels mediate persistent chronic stress-induced behavioral deficits that are associated with prefrontal cortex activation of the p25/Cdk5-glucocorticoid receptor pathway |
| Q34803447 | Cognitive remediation improves cognition and good cognitive performance increases time to relapse--results of a 5 year catamnestic study in schizophrenia patients |
| Q33606084 | Cognitive-behavioural therapy for psychosis: a status report |
| Q38124448 | Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings |
| Q37139004 | Convergence of genetic and environmental factors on parvalbumin-positive interneurons in schizophrenia |
| Q36093408 | Cortisol response to behavior problems in FMR1 premutation mothers of adolescents and adults with fragile X syndrome: A diathesis-stress model |
| Q34065935 | Elizabethan madness: on London's stage |
| Q51095407 | Emotional response as a function of symptoms in schizophrenia. |
| Q28210318 | Emotional responses to psychosocial stress in schizophrenia: the role of individual differences in affective traits and coping |
| Q51068060 | Family history of schizophrenia and the relationship of stress to symptoms: preliminary findings. |
| Q44230497 | Genetic susceptibility of mesocortical dopamine to stress determines liability to inhibition of mesoaccumbens dopamine and to behavioral 'despair' in a mouse model of depression |
| Q37719233 | Impact of substance use disorder on presentation and short-term course of schizophrenia |
| Q96306676 | Ketamine and neuroticism: a double-hit hypothesis of internalizing disorders |
| Q34604353 | Longitudinal study of stressful life events and daily stressors among adolescents at high risk for psychotic disorders |
| Q40026498 | Neglect and hereditary risk: Their relative contribution to schizophrenia with negative symptomatology |
| Q73235805 | Parallel strain-dependent susceptibility to environmentally-induced stereotypies and stress-induced behavioral sensitization in mice |
| Q36927085 | Pharmacotherapy of Co-Occurring Schizophrenia and Substance Use Disorders |
| Q43915856 | Predictable stress promotes place preference and low mesoaccumbens dopamine response |
| Q41491296 | Psychopharmacology of dopamine: the contribution of comparative studies in inbred strains of mice |
| Q34830420 | Social anhedonia and schizotypy in a community sample: the Maryland longitudinal study of schizotypy |
| Q51018708 | Spatial, object, and affective working memory in social anhedonia: an exploratory study. |
| Q36387420 | Stress axis dysfunction in schizophrenia |
| Q48498131 | Stress promotes major changes in dopamine receptor densities within the mesoaccumbens and nigrostriatal systems. |
| Q24621711 | Substance abuse and schizophrenia: pharmacotherapeutic intervention |
| Q38729376 | The link between schizophrenia and substance use disorder: A unifying hypothesis |
| Q36228225 | Treatment of substance use disorders in schizophrenia: a unifying neurobiological mechanism? |
| Q50785712 | Two sources of genetic liability to depression: interpreting the relationship between stress sensitivity and depression under a multifactorial polygenic model. |
| Q50138280 | Unique Effects of Clozapine: A Pharmacological Perspective |
| Q55072394 | Weak dorsolateral prefrontal response to social criticism predicts worsened mood and symptoms following social conflict in people at familial risk for schizophrenia. |
Search more.